Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“The Body’s Cellular Repair Crew, Mesenchymal stem cells (MSCs) are some of the most fascinating cells in regenerative medicine.
Found in bone marrow, fat tissue, umbilical cord tissue, and other organs, these cells can both transform into specialized cell types and influence healing through powerful signaling mechanisms.
What makes MSCs especially interesting is that their therapeutic potential may come less from ‘becoming new tissue’ and more from how they communicate with the immune system and damaged cells around them.
What MSCs can do:
- Modulate inflammation and immune responses
- Support tissue repair and wound healing
- Differentiate into bone, cartilage, muscle, and fat cells
- Release growth factors and extracellular vesicles that influence surrounding cells
- Serve as a major focus of regenerative medicine and bioengineering research
Researchers are actively studying MSCs in areas ranging from neurodegenerative disease and stroke recovery to orthopedic injury, autoimmune disorders, and cardiovascular disease.
The video of MSCs in motion is a reminder that biology is incredibly dynamic at the microscopic scale. These aren’t static structures — they constantly migrate, interact, signal, and adapt to their environment.
One of the most exciting shifts in recent years has been the growing understanding that stem cell therapies may work through entire cellular ecosystems, not just through cell replacement alone.
Credit to Nanolive SA for the great video!”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge